Join a LIVE WEBINAR with Dr. Joel M. Laudenbach and Dr. Paras Patel, where they explore oral cancer risk prediction and the STRATICYTE test in clinical practice 

Care to Know PRO Presents Peer Perspective.

Innovation in Oral Cancer Risk Prediction – The STRATICYTETM Test in Clinical Practice

Wednesday, June 11th, 2025 at 7:00pm EST

Join Dr. Joel M. Laudenbach, Dr. Paras Patel, and co-panelist Dr. Jaisri Thoppay, AAOM President-Elect, for an interactive discussion that includes a review of the challenges faced with the current standard of care, and how innovations like STRATICYTE are looking to transform oral precancer management. Our speakers will cover the science and data behind the novel STRATICYTE test while sharing examples of how STRATICYTE is used in practice to support decision making and compliance, including feedback from patients.

Live Online Link

Add to Calendar 

Dr. Joel M. Laudenbach
DMD Diplomate, American Boards of Oral Medicine & Dental Sleep Medicine, Clinical Associate Professor of Oral Medicine, Atrium Health Oral Medicine & Maxillofacial Surgery

Dr. Paras Patel
DDS Board Certified Oral and Maxillofacial Pathologist, Director of the Oral Maxillofacial Pathology Department at Propath, Owner and co-founder of the Center for Oral Pathology, Dallas Texas, Principal US Lab Director, Proteocyte 

Supported by: The America Academy of Oral Medicine

Promotional graphic for a webinar hosted by Dr. Joel M. Laudenbach and Dr. Paras Patel.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Proteocyte management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.